Reduction in 90 day readmission rates utilizing ambulatory pulmonary pressure monitoring

AIMS: In the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in New York Heart Association Functional Class III Heart Failure Patients) trial, heart failure hospitalization (HFH) rates were lower in patients with ambulatory pulmonary artery pressure (PAP) monitori...

Descripción completa

Detalles Bibliográficos
Autores principales: Valika, Ali, Sulemanjee, Nasir, Pedersen, Rachel, Heidenreich, Debra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871649/
https://www.ncbi.nlm.nih.gov/pubmed/36436826
http://dx.doi.org/10.1002/ehf2.14253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871649/
https://www.ncbi.nlm.nih.gov/pubmed/36436826
http://dx.doi.org/10.1002/ehf2.14253

Ejemplares similares